Our study aimed to explore the unknowns regarding absolute and relative risks of future skin cancers in patients with actinic keratoses(AKs). We performed a retrospective cohort using de-identified, random sample 4,999,999 fee-for-service Medicare beneficiaries aged ≥65 years (2009-2018). included treated AKs and, as comparator group, benign lesion seborrheic keratosis(SK). Both groups required...

Skin cancers may be derived from any part of the skin, and the classification of all variants is extensive. Overall they are the most common cancers of the body, and include those that are highly mortal and those that are associated with an increased morbidity. In this review the most common skin cancers confronted by the clinician and their management are discussed. New associations are highli...

The eyelid region is one of the most common sites for nonmelanoma skin cancers. In fact, skin cancers of the eyelid, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma, account for five to ten percent of all skin cancers. Ninety five percent of these tumors are basal cell carcinomas or squamous cell carcinomas [1,2]. A lower-eyelid reconstruction after cancer exti...

Ultraviolet radiation (UVR) has been identified as the primary etiologic agent for the induction and promotion of most skin cancers. The first associations between solar UVR and skin cancer were acknowledged by the scientific community in 1927. Since then, increasing evidence for the role of UVR in the causation of skin cancer has resulted in the listing of solar and artificial UVR as a human c...

  Introduction: Using beta emitter radionuclide is a useful therapeutic modality in the treatment of skin cancers in areas which are difficult to cure by other methods. The aim of this research is to evaluate the tissue response to beta rays of 166Ho and determine the feasibility of beta emitting radionuclide for treatment of skin cancers. Methods: In this...